LYTIR

Company · PALI

Palisade Bio, Inc.

Name as listed on its exchange; filed with the SEC as PALISADE BIO, INC.

Nasdaq's symbol directory lists PALI on Nasdaq as “Palisade Bio, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 8 occasions ($279K); insiders sold on 2 occasions ($410K); 7 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $279K in total; Insider sales: $410K in total.Jul: Insider purchases $250KJul: Insider sales $410KOct: Insider purchases $29KDecJanFebMarAprMayJunJulAugSepOctNov$250K$410K
Insider purchases above the line: $279KInsider sales below: $410K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Finley John David, CEO, CFO sold on 1 day latest Jul 7, 2026 sold $303K
  2. Robert Baltera Jr. bought on 6 days latest Jul 9, 2026 bought $250K
  3. Jones Mitchell Lawrence, Chief Medical Officer sold on 1 day latest Jul 7, 2026 sold $107K
  4. Donald Allen Williams bought on 2 days latest Oct 2, 2026 bought $29K
Every trade (10)
  1. BUYDonald Allen Williams bought Oct 2, 2026 10,000 shares filing $15K
  2. BUYDonald Allen Williams bought Oct 1, 2026 10,000 shares filing $14K
  3. BUYRobert Baltera Jr. bought Jul 9, 2026 25,000 shares filing $49K
  4. BUYRobert Baltera Jr. bought Jul 8, 2026 20,000 shares filing $40K
  5. SELLFinley John David, CEO, CFO sold Jul 7, 2026 146,798 shares filing $303K
  6. SELLJones Mitchell Lawrence, Chief Medical Officer sold Jul 7, 2026 51,880 shares filing $107K
  7. BUYRobert Baltera Jr. bought Jul 7, 2026 30,000 shares filing $61K
  8. BUYRobert Baltera Jr. bought Jul 6, 2026 20,000 shares filing $41K
  9. BUYRobert Baltera Jr. bought Jul 2, 2026 10,000 shares filing $20K
  10. BUYRobert Baltera Jr. bought Jul 1, 2026 20,000 shares filing $40K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. RA Capital Management, L.P. filed Nov 16, 2026 Schedule 13G/A passive filing 9.9%
  2. Ameriprise Financial, Inc. filed Nov 16, 2026 Schedule 13G/A passive filing 8.4%
  3. Soleus Capital Master Fund, L.P. filed Nov 9, 2026 Schedule 13G/A passive filing 8.6%
  4. Vanguard Capital Management filed Oct 30, 2026 Schedule 13G passive 8,995,805 shares filing 5.16%
  5. Commodore Capital LP filed Aug 14, 2026 Schedule 13G/A passive filing 0%
  6. Soleus Capital Master Fund, L.P. filed Aug 13, 2026 Schedule 13G/A passive filing 7.5%
  7. BlackRock, Inc. filed Jul 29, 2026 Schedule 13G passive 10,436,760 shares filing 6%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 10, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.